Short-sellers have been ramping up their positions in both Editas Medicine and Bluebird Bio lately. With multiple options on the table, Editas and Bluebird could both blaze the comeback trail. Editas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback